Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth

MeSH terms

• Breast Neoplasms / therapy*
• Female
• Humans
• Ovarian Cysts / chemically induced*
• Ovarian Cysts / pathology
• Ovary / diagnostic imaging
• Ovary / drug effects
• Ovary / pathology
• Premenopause
• Tamoxifen / adverse effects*
• Tamoxifen / therapeutic use
• Ultrasonography
• Uterine Diseases / chemically induced*
• Uterine Diseases / pathology
• Uterus / diagnostic imaging
• Uterus / drug effects
• Uterus / pathology